actions

PowerShares Emerging Markets Sovereign Debt Portfolio (PCX:PCY)

The PowerShares Emerging Markets Sovereign Debt Portfolio ETF (PCY) invests in emerging market sovereign bonds with an attractive yield of 6.38%. Despite a slightly high volatility of 10.21%, this ETF offers protection against dollar fluctuations and monthly distributions, making it an attractive instrument to diversify your portfolio.

PowerShares Emerging Markets Sovereign Debt Portfolio (PCX:PCY) Read More »

New strategy

Discover the new “Ex-US International ETFs and Dividend Stocks” strategy, which combines European stocks and ETFs for a solid return against currency risks. Optimize your portfolio with this diversified selection, ideal for investors looking for long-term profitability.

New strategy Read More »

Novartis (VTX:NOVN)

Discover the detailed analysis of Novartis, the pharmaceutical giant born from the merger of Ciba-Geigy and Sandoz, and its dividend policy that raises ethical and economic questions. Between job cuts and sustainable dividend growth, let's explore how this global leader in pharma balances its social responsibilities and financial performance.

Novartis (VTX:NOVN) Read More »

Dividends: Back to basics

In an insightful analysis published in Les Echos, Gilles Coville explores the resurgence of dividends as a pillar of investment, highlighting their historical importance and their crucial role in stock performance. This trend marks a return to normal according to David Shairp of JP Morgan AM, who highlights the reliability of dividends as an indicator of the financial health of companies and their appeal to investors seeking stable returns over the long term.

Dividends: Back to basics Read More »

Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson, an American healthcare giant founded in 1886, is one of the world's largest manufacturers of pharmaceutical, medical and cosmetic products with iconic brands such as Tylenol, Band-Aid and Neutrogena. The company stands out for its impressive history of growing dividends for decades, offering attractive stability for investors despite a slightly high payout ratio.

Johnson & Johnson (NYSE:JNJ) Read More »